Physician profile
Eri Gibb
NPI 1679989420
$425.50
in general payments reported to CMS, 2019-2025
11 companies · $37.05 in 2025
The $37.05 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $43.31 · 2021: $81.90 · 2022: $72.21 · 2023: $44.57 · 2025: $37.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $214.24 | 2019-2025 | |
| Dexcom, INC. | $59.77 | 2022-2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $24.96 | 2019 | |
| Nevro Corp. | $24.85 | 2023 | Senza |
| Glaxosmithkline, LLC. | $17.44 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.21 | 2021 | |
| Bardy Diagnostics, INC. | $14.72 | 2022 | |
| Abbvie INC. | $14.01 | 2021 | |
| Merck Sharp & Dohme LLC | $13.71 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.69 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eri Gibb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.